Govt to provide Rs 900 crore for Covid Vaccine Research and Development
PBT Raises Rs 18 Crore on Social Stock Exchange for Free Healthcare Initiative
New Delhi: The government will provide Rs 900 crore to the Department of Biotechnology for the Covid Suraksha Mission, Finance Minister Nirmala Sitharaman said on Thursday while announcing another stimulus package, as part of 'Aatmanirbhar Bharat 3.0'.
The government grant will be used for research and development (R&D) of the Indian Covid vaccine.
Announcing the R&D fund, Sitharaman said that it would only cater to identified activity and would not cover the cost of vaccine or logistics required for its development. These will be provided separately, she said.
Indian companies like the Serum Institute and Bharat Biotech are conducting trials for Covid vaccines in the country and are most likely candidates to produce it when all necessary permissions are given.
The Finance Minister also announced Rs 10,200 crore additional budget outlay for capital and industrial expenditure.
This allocation will go into strengthening domestic manufacturing capabilities, especially in areas of defence equipment and green energy equipment.
Read also: Zydus Cadila Covid therapy PegiHep completes Phase II trial
The additional money will also support rolling out of industrial incentives and facilitate development of industrial infrastructure.
Sitharaman said that this spend will be in addition to what had already been provided for boosting capital expenditure and supporting local industries.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.